Amazon eyeing investment in Indian pharmacy chain

Amy Baxter | | Health Exec | Policy & Regulations
Amazon logo

Photo by Anna Shvets via Pexels

Retail giant Amazon is in early talks to invest in Medplus, India’s second-largest pharmacy chain, according to FactorDaily. The two companies are only in preliminary discussions—and it is “too early to call it a deal,” sources told FactorDaily.

Medplus was founded in 2006 and runs more than 1,400 across 12 Indian states.

A potential investment in a pharmacy benefits manager like Medplus should come as no surprise. Amazon has made increasingly larger moves into the healthcare space, including launching its own line of over-the-counter medicines and teaming up with JPMorgan and Berkshire Hathaway to form a new healthcare venture.

Amazon also recently acquired online pharmacy PillPack for about $1 billion.

See the full report here:

Amazon in talks to buy Medplus, India’s No. 2 pharmacy chain

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

5 healthcare AI predictions for 2025 from Wolters Kluwer Health
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.